Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 235 posts found.

FTC building

Federal Trade Commission sues AbbVie and Teva

September 9, 2014
Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission

Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …

News

Teva launches new MS eHealth site

September 4, 2014
Medical Communications, Sales and Marketing Teva, digital, ms ireland, multiple sclerosis, pow health

Teva and MS Ireland have helped launch a new website called Pow Health to give multiple sclerosis patients a “one-stop …

News
atorvastatin

Copycat Lipitor helps toward £1.3bn NHS savings

July 29, 2014
Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba

In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …

News
servier image

Servier fined €331m by European Commission

July 10, 2014
Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva

The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …

News
Dr Phillip Frost image

Teva chairman stepping down amid revamp

June 19, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

News
Teva image

Teva to close half its sites

June 17, 2014
Manufacturing and Production, Sales and Marketing Jobs, Teva, cuts, generics, manufacturing

Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …

News
Teva image

Teva considers up to 27 plant closures

May 13, 2014
Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics

Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …

News

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

News
GSK image

CHMP breathes new life into GSK, Teva and Novartis

February 24, 2014
Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro

The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …

News
Teva image

Teva under investigation for marketing practices

February 12, 2014
Sales and Marketing Azilect, Copaxone, Teva, fines, generics

Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …

News

Teva/VCCP on top at PM Society ad awards

February 3, 2014
Medical Communications, Sales and Marketing 2014, Teva, ads, advertising, neil smith, pm awards, vccp

Teva and its agency partner VCCP took home the most wins from this year’s PM Society Advertising Awards that featured …

News
screen_shot_2014-01-29_at_10

High-dose Copaxone the right medicine for Teva

January 29, 2014
Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva

The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …

News
Teva image

Teva’s Great White Hope knocked back by Europe

January 27, 2014
Sales and Marketing CHMP, EU, MS, Nerventra, Teva

The drug designed to be a follow-up to Teva’s wildly successful Copaxone has been hit by rejection in Europe, leaving …

News
Erez Vigodman image

Teva names new chief executive

January 9, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Levin, Teva, erez vigodman, generics

The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …

News
amir_elstein

Teva vice chairman quits

December 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, amir elstein, moshe many

Teva Pharmaceuticals vice chairman Professor Moshe Many has requested to leave the firm at the end of this month for …

Appointment
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026